Tumor suppressor p53 mutations and breast cancer: a critical analysis (Q34314048)

1 August 2017

title

Tumor suppressor p53 mutations and breast cancer: a critical analysis (English)

1 reference

1 August 2017

Tumor Suppressor p53 Mutations and Breast Cancer: A Critical Analysis (English)

0 references

1 reference

2

Janet S. Butel

Butel JS

1 reference

1 August 2017

1

Michelle A. Ozbun

1 reference

1 August 2017

publication date

1 January 1995

1 reference

Advances in Cancer Research

1 August 2017

1995

0 references

published in

1 reference

1 August 2017

volume

66

1 reference

1 August 2017

page(s)

71-141

1 reference

publication type of scholarly work

1 August 2017

review article

1 reference

Regulation of the human hsp70 promoter by p53

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Immunologically distinct p53 molecules generated by alternative splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Suppression of human colorectal carcinoma cell growth by wild-type p53

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

mdm2 expression is induced by wild type p53 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Abnormal expression of wild type p53 protein in normal cells of a cancer family patient

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

An intron binding protein is required for transformation ability of p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Changes in p53 mRNA expression during terminal differentiation of murine erythroleukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Cancer statistics, 1991.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Mouse p53 inhibits SV40 origin-dependent DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 mutations, another breast cancer prognostic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Somatic mutations and human breast cancer. A status report

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Rainbow trout p53: cDNA cloning and biochemical characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

TP53 tumor suppressor gene: a model for investigating human mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

A new mutation of exon 5 of the P53 gene in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

P53 expression in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The amount of a specific cellular protein (p53) is a correlate of differentiation in embryonal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Immunohistochemical analysis of p53 and HER-2/neu proteins in human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Mapping of the p53 and mdm-2 Interaction Domains

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Genetic mechanisms of tumor suppression by the human p53 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Degradation of nuclear oncoproteins by the ubiquitin system in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Thymocyte apoptosis induced by p53-dependent and independent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Purification of complexes of nuclear oncogene p53 with rat and Escherichia coli heat shock proteins: in vitro dissociation of hsc70 and dnaK from murine p53 by ATP.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Evidence for allosteric variants of wild-type p53, a tumour suppressor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The gene and the pseudogene for mouse p53 cellular tumor antigen are located on different chromosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Genetic basis for p53 overexpression in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The Tumor Suppressor p53 Regulates Its Own Transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 functions as a cell cycle control protein in osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Gain of function mutations in p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Inhibition of DNA replication factor RPA by p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Definition of a consensus binding site for p53

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Wild-type p53 can inhibit oncogene-mediated focus formation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Overproduction of p53 antigen makes established cells highly tumorigenic

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Participation of p53 cellular tumour antigen in transformation of normal embryonic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Prognostic significance of p53 gene alterations in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Wild-type p53 activates transcription in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Identification of a chromosome 18q gene that is altered in colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Presence of a potent transcription activating sequence in the p53 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The p53 proto-oncogene can act as a suppressor of transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 is covalently linked to 5.8S rRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Isolation and characterization of DNA sequences that are specifically bound by wild-type p53 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The p53 protein is an unusually shaped tetramer that binds directly to DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Overexpression of p53 and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

A transcriptionally active DNA-binding site for human p53 protein complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Evidence that immunological variants of p53 represent alternative protein conformations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Antimicrobial peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Wild-type p53 can down-modulate the activity of various promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Energy Requirement for Degradation of Tumor-Associated Protein p53

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Wild-type p53 adopts a 'mutant'-like conformation when bound to DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Stabilization of the p53 transformation-related protein in mouse fibrosarcoma cell lines: effects of protein sequence and intracellular environment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Different tumor-derived p53 mutants exhibit distinct biological activities

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Alternatively spliced p53 RNA in transformed and normal cells of different tissue types

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

1 reference

7 January 2021

Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The transactivator proteins VP16 and GAL4 bind replication factor A.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Functional inactivation of genes by dominant negative mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 immunostaining in benign breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

A TP53 mutation detected in cells established from an osteosarcoma, but not in the retinoblastoma of a patient with bilateral retinoblastoma and multiple primary osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Structure of the rat p53 tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Cooperation between oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Regulation of the specific DNA binding function of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Activation of the cryptic DNA binding function of mutant forms of p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Cloning and expression analysis of full length mouse cDNA sequences encoding the transformation associated protein p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Expression of wild-type p53 is not compatible with continued growth of p53-negative tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Identification of p53 as a sequence-specific DNA-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Oncogenic forms of p53 inhibit p53-regulated gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The relationship between age and incidence of breast cancer. Population and screening program data

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Early events in murine erythroleukemia cells induced to differentiate. Accumulation and gene expression of the transformation-associated cellular protein p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Loss of heterozygosity at chromosome 17p is associated with HER-2 amplification and lack of nodal involvement in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Direct sequencing from touch preparations of human carcinomas: analysis of p53 mutations in breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Correlation of metabolic stability and altered quaternary structure of oncoprotein p53 with cell transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 mutations are absent from carcinogen-induced mouse liver tumors but occur in cell lines established from these tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Wild-type p53 is a cell cycle checkpoint determinant following irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

hsp70 binds specifically to a peptide derived from the highly conserved domain (I) region of p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Characterization of the human p53 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

A death in the life of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53: oncogene or anti-oncogene?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

T antigen is bound to a host protein in SY40-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Tumour suppressor genes and molecular chaperones.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 mutations increase resistance to ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The cDNA cloning and immunological characterization of hamster p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Transformation by simian virus 40 does not involve the mutational activation of p53 to an oncogenic form

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The phosphoprotein p53 is down-regulated post-transcriptionally during embryogenesis in vertebrates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 is required for radiation-induced apoptosis in mouse thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Tissue-specific expression of p53 in transgenic mice is regulated by intron sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Allele loss on short arm of chromosome 17 in breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Physical and functional interaction between WT1 and p53 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

UV Irradiation Stimulates Levels of p53 Cellular Tumor Antigen in Nontransformed Mouse Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Characteristic karyotypic anomalies identify subtypes of malignant fibrous histiocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Epidemiology. Search for a killer: focus shifts from fat to hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Rearrangement of the p53 gene in human osteogenic sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

SV40 T antigen binds specifically to a cellular 53 K protein in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The preneoplastic state in mouse mammary tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Immortalization phenotype dissociated from the preneoplastic phenotype in mouse mammary epithelial outgrowths in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Phosphorylation of p53 in normal and simian virus 40-transformed NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Role of the p53 Protein in Cell Proliferation as Studied by Microinjection of Monoclonal Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Breast cancer risk factors. Contributions to planning breast cancer control

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 mutations: gains or losses?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Localization of gene for human p53 tumour antigen to band 17p13.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Mutation of the casein kinase II phosphorylation site abolishes the anti-proliferative activity of p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Different forms of p53 detected by monoclonal antibodies in non-dividing and dividing lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

A conformation hypothesis for the suppressor and promoter functions ofp53in cell growth control and in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The cellular tumour antigen p53: evidence for transformation-related, immunological variants of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Temperature-dependent switching between "wild-type" and "mutant" forms of p53-Val135.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Quantitative analysis of cell surface-associated SV40 large T antigen using a newly developed 3H-protein A binding assay

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Tumor suppressor p53: analysis of wild-type and mutant p53 complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Mutations in the p53 gene occur in diverse human tumour types

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Human p53 and CDC2Hs genes combine to inhibit the proliferation of Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53-catalyzed annealing of complementary single-stranded nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Amplification of a gene encoding a p53-associated protein in human sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Post-Translational Regulation of the 54K Cellular Tumor Antigen in Normal and Transformed Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Regulation of the Cellular p53 Tumor Antigen in Teratocarcinoma Cells and Their Differentiated Progeny

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Anatomic markers of human premalignancy and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The amino acid sequence of murine p53 determined from a c-DNA clone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Sequence-specific transcriptional activation is essential for growth suppression by p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

No room at the p53 inn

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Expression of the mouse p53 cellular tumor antigen in monkey cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Specific interaction between the p53 cellular tumour antigen and major heat shock proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 increases experimental metastatic capacity of murine carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The p53 tumor suppressor protein: meeting review

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Constitutional p53 mutation in a non-Li-Fraumeni cancer family

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Analysis of p53 mutants for transcriptional activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Growth regulation of a cellular tumour antigen, p53, in nontransformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Two Distinct Mechanisms Regulate the Levels of a Cellular Tumor Antigen, p53

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Human p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within intron 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

5-Methylcytosine as an Endogenous Mutagen in the Human LDL Receptor and p53 Genes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Nucleotide sequence of a cDNA encoding the monkey cellular phosphoprotein p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 mutations in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Expression from the murine p53 promoter is mediated by factor binding to a downstream helix-loop-helix recognition motif

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

P53 transformation-related protein accumulates in the nucleus of transformed fibroblasts in association with the chromatin and is found in the cytoplasm of non-transformed fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Chromosomal Assignment of the Murine Gene Encoding the Transformation-Related Protein p53

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Mutations in p53 as potential molecular markers for human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The tumor suppressor p53 is bound to RNA by a stable covalent linkage

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Point mutation of the p53 gene resulting in splicing inhibition in small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 germline mutations in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Mammalian p53 can function as a transcription factor in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Cyclin E enhances P53-mediated transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Wild-type p53 binds to the TATA-binding protein and represses transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Tight DNA binding and oligomerization are dispensable for the ability of p53 to transactivate target genes and suppress transformation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Toward a molecular understanding of human breast cancer: a hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell division

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Negative regulation of Rb expression by the p53 gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

A DNA binding domain is contained in the C-terminus of wild type p53 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 as an independent prognostic marker in lymph node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Human breast cancer: frequent p53 allele loss and protein overexpression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Transforming activity of mutant human p53 alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Pattern of p53 Gene Mutations in Breast Cancers of Women of the Midwestern United States

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Nucleotide sequence of a cDNA encoding the chicken p53 nuclear oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Nm23 and breast cancer metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Formation of stable p53 homotetramers and multiples of tetramers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Cellular accumulation of p53 protein: an independent prognostic factor in stage II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Mutant conformation of p53. Precise epitope mapping using a filamentous phage epitope library

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The p53 gene in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Characterization of mutant p53-hsp72/73 protein-protein complexes by transient expression in monkey COS cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Enhanced protein phosphorylation in SV40-transformed and -infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Inhibition of DNA synthesis by TGF-beta 1 coincides with inhibition of phosphorylation and cytoplasmic translocation of p53 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Protein synthesis-dependent cytoplasmic translocation of p53 protein after serum stimulation of growth-arrested MCF-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Association of insulin-like growth-factor-I-induced DNA synthesis with phosphorylation and nuclear exclusion of p53 in human breast cancer MCF-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 gene mRNA expression and chromosome 17p allele loss in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Prognostic significance of p53 overexpression in node-negative breast carcinoma: preliminary studies support cautious optimism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Characterization of the human p53 gene promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16)(q13;p11) in myxoid liposarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The multistep nature of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Expression of p53 protein in infiltrating and in-situ breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

p53 domains: identification and characterization of two autonomous DNA-binding regions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Phosphorylation sites in the amino-terminal region of mouse p53

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The MCK enhancer contains a p53 responsive element

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

The p53-mdm-2 autoregulatory feedback loop

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Direct growth stimulation of normal human epithelial cells by mutant p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

P53 in tumour pathology: can we trust immunocytochemistry?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

A single gene and a pseudogene for the cellular tumour antigen p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53 - MDM2 complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Induction of cellular p53 activity by DNA-damaging agents and growth arrest.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Targeting frequency for deletion vectors in embryonic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Spontaneous rearrangement of integrated simian virus 40 DNA in nine transformed rodent cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Oligomerization of oncoprotein p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Simian virus 40 large T antigen induces or activates a protein kinase which phosphorylates the transformation-associated protein p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

Monoclonal antibody analysis of p53 expression in normal and transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

A comparison of the biological activities of wild-type and mutant p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960252-3

7 January 2021

10.1016/S0065-230X(08)60252-3

Identifiers

DOI

0 references

1 reference